Publications 2012

Ueland T, Aukrust P, Aakhus S, Smith C, Endresen K, Birkeland KI, Gullestad L, Johansen OE (2012)
Activin A and cardiovascular disease in type 2 diabetes mellitus
Diabetes Vasc. Dis. Res., 9 (3), 234-237
DOI 10.1177/1479164111431171

Publications 2011

Andersen GO, Ueland T, Knudsen EC, Scholz H, Yndestad A, Sahraoui A, Smith C, Lekva T, Otterdal K, Halvorsen B, Seljeflot I, Aukrust P (2011)
Activin A Levels Are Associated With Abnormal Glucose Regulation in Patients With Myocardial Infarction Potential Counteracting Effects of Activin A on Inflammation
Diabetes, 60 (5), 1544-1551
DOI 10.2337/db10-1493

Publications 2010

Halvorsen B, Heggen E, Ueland T, Smith C, Sandberg WJ, Damas JK, Otterdal K, Tonstad S, Aukrust P (2010)
Treatment with the PPAR gamma agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome
Eur. J. Endocrinol., 162 (2), 267-273
DOI 10.1530/EJE-09-0706

Publications 2009

Jansson AM, Aukrust P, Ueland T, Smith C, Omland T, Hartford M, Caidahl K (2009)
Soluble CXCL16 Predicts Long-Term Mortality in Acute Coronary Syndromes
Circulation, 119 (25), 3181-3188
DOI 10.1161/CIRCULATIONAHA.108.806877

Sandberg WJ, Halvorsen B, Yndestad A, Smith C, Otterdal K, Brosstad FR, Froland SS, Olofsson PS, Damas JK, Gullestad L, Hansson GK, Oie E, Aukrust P (2009)
Inflammatory Interaction Between LIGHT and Proteinase-Activated Receptor-2 in Endothelial Cells Potential Role in Atherogenesis
Circ.Res., 104 (1), 60-U192
DOI 10.1161/CIRCRESAHA.108.188078

Yndestad A, Larsen KO, Oie E, Ueland T, Smith C, Halvorsen B, Sjaastad I, Skjonsberg OH, Pedersen TM, Anfinsen OG, Damas JK, Christensen G, Aukrust P, Andreassen AK (2009)
Elevated levels of activin A in clinical and experimental pulmonary hypertension
J. Appl. Physiol., 106 (4), 1356-1364
DOI 10.1152/japplphysiol.90719.2008

Publications 2008

Aukrust P, Otterdal K, Yndestad A, Sandberg WJ, Smith C, Ueland T, Oie E, Damas JK, Gullestad L, Halvorsen B (2008)
The Complex Role of T-Cell-Based Immunity in Atherosclerosis
Curr. Atherosclerol. Rep., 10 (3), 236-243
DOI 10.1007/s11883-008-0037-8

Breland UM, Halvorsen B, Hol J, Oie E, Paulsson-Berne G, Yndestad A, Smith C, Otterdal K, Hedin U, Waehre T, Sandberg WJ, Froland SS, Haraldsen G, Gullestad L, Damas JK, Hansson GK, Aukrust P (2008)
A potential role of the CXC chemokine GRO alpha in atherosclerosis and plaque destabilization - Downregulatory effects of statins
Arterioscler. Thromb. Vasc. Biol., 28 (5), 1005-1011
DOI 10.1161/ATVBAHA.108.162305

Omland T, Ueland T, Jansson AM, Persson A, Karlsson T, Smith C, Herlitz J, Aukrust P, Hartford M, Caidahl K (2008)
Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes
J. Am. Coll. Cardiol., 51 (6), 627-633
DOI 10.1016/j.jacc.2007.09.058

Smith C (2008)
Immunopathogenic mechanisms of coronary artery disease and plaque destabilization
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 599, 1 b. (flere pag.)
BIBSYS 08029877x, ISBN 978-82-8072-725-1

Smith C, Halvorsen B, Otterdal K, Waehre T, Yndestad A, Fevang B, Sandberg WJ, Breland UM, Froland SS, Oie E, Gullestad L, Damas JK, Aukrust P (2008)
High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins
Cardiovasc. Res., 79 (1), 195-203
DOI 10.1093/cvr/cvn071

Publications 2007

Aukrust P, Yndestad A, Smith C, Ueland T, Gullestad L, Damas JK (2007)
Chemokines in cardiovascular risk prediction
Thromb. Haemost., 97 (5), 748-754
DOI 10.1160/TH07-01-0029

Dahl TB, Yndestad A, Skjelland M, Oie E, Dahl A, Michelsen A, Damas JK, Tunheim SH, Ueland T, Smith C, Bendz B, Tonstad S, Gullestad L, Froland SS, Krohg-Sorensen K, Russell D, Aukrust P, Halvorsen B (2007)
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis - Possible role in inflammation and plaque destabilization
Circulation, 115 (8), 972-980
DOI 10.1161/CIRCULATIONAHA.106.665893

Damas JK, Smith C, Oie E, Fevang B, Halvorsen B, Waehre T, Boullier A, Breland U, Yndestad A, Ovchinnikova O, Robertson AKL, Sandberg WJ, Kjekshus J, Tasken K, Froland SS, Gullestad L, Hansson GK, Quehenberger O, Aukrust P (2007)
Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis - Possible pathogenic role in plaque destabilization
Arterioscler. Thromb. Vasc. Biol., 27 (3), 614-620
DOI 10.1161/01.ATV.0000255581.38523.7c

Publications 2006

Otterdal K, Smith C, Oie E, Pedersen TM, Yndestad A, Stang E, Endresen K, Solum NO, Aukrust P (2006)
Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes
Blood, 108 (3), 928-935
DOI 10.1182/blood-2005-09-010629

Smith C, Damas JK, Otterdal K, Oie E, Sandberg WJ, Yndestad A, Waehre T, Scholz H, Endresen K, Olofsson PS, Halvorsen B, Gullestad L, Froland SS, Hansson GK, Aukrust P (2006)
Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes - Possible role of platelet-mediated vascular inflammation
J. Am. Coll. Cardiol., 48 (8), 1591-1599
DOI 10.1016/j.jacc.2006.06.060